545 related articles for article (PubMed ID: 23071781)
1. The lung microbiome in moderate and severe chronic obstructive pulmonary disease.
Pragman AA; Kim HB; Reilly CS; Wendt C; Isaacson RE
PLoS One; 2012; 7(10):e47305. PubMed ID: 23071781
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of the lung microbiota of cynomolgous macaques during long-term SHIV infection.
Morris A; Paulson JN; Talukder H; Tipton L; Kling H; Cui L; Fitch A; Pop M; Norris KA; Ghedin E
Microbiome; 2016 Jul; 4(1):38. PubMed ID: 27391224
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis of the lung microbiome in lung transplantation.
Borewicz K; Pragman AA; Kim HB; Hertz M; Wendt C; Isaacson RE
FEMS Microbiol Lett; 2013 Feb; 339(1):57-65. PubMed ID: 23173619
[TBL] [Abstract][Full Text] [Related]
4. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
[TBL] [Abstract][Full Text] [Related]
5. Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.
Wu X; Wei X; Li X; Deng J; Zhang J
Jpn J Infect Dis; 2022 Nov; 75(6):560-568. PubMed ID: 35908874
[TBL] [Abstract][Full Text] [Related]
6. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
Wu Y; Luo Z; Liu C
Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the lung microbiome in the "healthy" smoker and in COPD.
Erb-Downward JR; Thompson DL; Han MK; Freeman CM; McCloskey L; Schmidt LA; Young VB; Toews GB; Curtis JL; Sundaram B; Martinez FJ; Huffnagle GB
PLoS One; 2011 Feb; 6(2):e16384. PubMed ID: 21364979
[TBL] [Abstract][Full Text] [Related]
8. COPD and the microbiome.
Mammen MJ; Sethi S
Respirology; 2016 May; 21(4):590-9. PubMed ID: 26852737
[TBL] [Abstract][Full Text] [Related]
9. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
F1000Res; 2023; 12():528. PubMed ID: 37928173
[No Abstract] [Full Text] [Related]
10. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
[TBL] [Abstract][Full Text] [Related]
11. Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.
Lee SW; Kuan CS; Wu LS; Weng JT
PLoS One; 2016; 11(7):e0159066. PubMed ID: 27428540
[TBL] [Abstract][Full Text] [Related]
12. The lung tissue microbiome in chronic obstructive pulmonary disease.
Sze MA; Dimitriu PA; Hayashi S; Elliott WM; McDonough JE; Gosselink JV; Cooper J; Sin DD; Mohn WW; Hogg JC
Am J Respir Crit Care Med; 2012 May; 185(10):1073-80. PubMed ID: 22427533
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures.
Gupta S; Shariff M; Chaturvedi G; Sharma A; Goel N; Yadav M; Mortensen MS; Sørensen SJ; Mukerji M; Chauhan NS
Sci Rep; 2021 Feb; 11(1):3963. PubMed ID: 33597669
[TBL] [Abstract][Full Text] [Related]
14. Alveolar microbiota profile in patients with human pulmonary tuberculosis and interstitial pneumonia.
Vázquez-Pérez JA; Carrillo CO; Iñiguez-García MA; Romero-Espinoza I; Márquez-García JE; Falcón LI; Torres M; Herrera MT
Microb Pathog; 2020 Feb; 139():103851. PubMed ID: 31715320
[TBL] [Abstract][Full Text] [Related]
15. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.
Li W; Wang B; Tan M; Song X; Xie S; Wang C
Respir Res; 2022 Nov; 23(1):321. PubMed ID: 36403054
[TBL] [Abstract][Full Text] [Related]
16. The development of lower respiratory tract microbiome in mice.
Singh N; Vats A; Sharma A; Arora A; Kumar A
Microbiome; 2017 Jun; 5(1):61. PubMed ID: 28637485
[TBL] [Abstract][Full Text] [Related]
17. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Oral Microbiomes of Canines and Their Owners Using Next-Generation Sequencing.
Oh C; Lee K; Cheong Y; Lee SW; Park SY; Song CS; Choi IS; Lee JB
PLoS One; 2015; 10(7):e0131468. PubMed ID: 26134411
[TBL] [Abstract][Full Text] [Related]
19. The sputum microbiome is distinct between COPD and health, independent of smoking history.
Haldar K; George L; Wang Z; Mistry V; Ramsheh MY; Free RC; John C; Reeve NF; Miller BE; Tal-Singer R; Webb AJ; Brookes AJ; Tobin MD; Singh D; Donaldson GC; Wedzicha JA; Brown JR; Barer MR; Brightling CE
Respir Res; 2020 Jul; 21(1):183. PubMed ID: 32664956
[TBL] [Abstract][Full Text] [Related]
20. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E
J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
